1018678-49-3 Usage
Description
[2-(Difluoromethyl)phenyl]methanol, 2-(Hydroxymethyl)benzal fluoride are organic compounds with unique chemical structures and properties, which hold potential applications in the pharmaceutical and chemical industries.
Usage:
Used in Pharmaceutical Industry:
[2-(Difluoromethyl)phenyl]methanol, 2-(Hydroxymethyl)benzal fluoride is used as a key intermediate for the synthesis of various pharmaceuticals and agrochemicals due to their unique chemical structures that can be further modified for specific therapeutic applications.
Used in Chemical Industry:
[2-(Difluoromethyl)phenyl]methanol, 2-(Hydroxymethyl)benzal fluoride is used as a building block for the synthesis of other organic compounds, taking advantage of their reactive functional groups to create a wide range of products with diverse applications in the chemical sector.
Check Digit Verification of cas no
The CAS Registry Mumber 1018678-49-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,8,6,7 and 8 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1018678-49:
(9*1)+(8*0)+(7*1)+(6*8)+(5*6)+(4*7)+(3*8)+(2*4)+(1*9)=163
163 % 10 = 3
So 1018678-49-3 is a valid CAS Registry Number.
1018678-49-3Relevant articles and documents
PYRIDAZINONES AND METHODS OF USE THEREOF
-
Page/Page column 168; 169, (2019/04/11)
Disclosed are compounds according to Formula (A), and related tautomers and pharmaceutical compositions. Also disclosed are therapeutic methods, e.g., of treating kidney diseases, using the compounds of Formula (A).
PYRIDO [4,3-d] PYRIMIDIN-4 (3H) -ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS
-
Page/Page column 21, (2008/06/13)
The present invention is directed to novel pyrido[4,3-d]pyrimidin-4(3H)-one derivatives and pharmaceutically acceptable salts thereof of structural formula I wherein the variables R1, R2, R3, R4 and R5 are as described herein. Also provided are pharmaceutical compositions comprising the compounds of formula I as well as methods of treatment employing compounds of formula I to treat a disease or disorder characterized by abnormal bone or mineral homeostasis such as hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy.
